Source: Annual Congress 2006 - Various parenchymal lung diseases and pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
K. Sallinen, A. Jartti, A. Karjalainen, R. Kaarteenaho-Wiik (Oulu, Finland). Pulmonary and pleural manifestations in scleroderma. Eur Respir J 2006; 28: Suppl. 50, 2269

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary sarcoidosis Source: Eur Respir Monogr 2022; 96: 122-141 Year: 2022 Pulmonary vasculitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Pulmonary vasculitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Pulmonary vasculitis Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Pulmonary vasculitis Source: ERS Course 2016 Year: 2016 Pathogenesis of pulmonary fibrosis in sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Pulmonary hypertension complicating fibrosing mediastinitis Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016 Pulmonary manifestations of systemic vasculitis in childhood Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020 Year: 2020 Systemic manifestations of sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 95s Year: 2006 Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Neoplastic markers in pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Pulmonary involvement of systemic histiocytic disorders Source: Eur Respir Monogr 2019; 86: 359-373 Year: 2019 Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis? Source: International Congress 2014 – ILDs 1 Year: 2014 Sarcoidosis: pulmonary manifestations and management Source: Eur Respir Monogr 2019; 86: 404-418 Year: 2019 Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Drug-induced eosinophilic pleural effusion Source: Eur Respir Rev 2011; 20: 300-301 Year: 2011